Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | ECE1 | P42892 | 3/20 | 0.35 |
| ▸ | FAAH | O00519 | 2/20 | 0.34 |
| ▸ | CNR1 | P21554 | 2/20 | 0.34 |
| ▸ | CNR2 | P34972 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | NAMPT | P43490 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | ITGB3 | P05106 | 2/20 | 0.33 |
| ▸ | ITGA2B | P08514 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | FPR2 | P25090 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | CCKBR | P32239 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31447851 | 0.81 | LMNA (0.32) | ALDH1A1LMNANAMPTHPGDHSD17B10 | |
| SCHEMBL30529639 | 0.80 | SMN1; SMN2 (0.45) | ALDH1A1LMNAPKMTSHRHPGD | |
| Trifluoroacetic Acid SCHEMBL27959221 | 0.76 | ALDH1A1 (0.35) | ALDH1A1LMNAPKMITGB3ITGA2B | |
| SCHEMBL11927649 | 0.74 | PTGS1 (0.54) | ALDH1A1FAAHCNR1CNR2LMNA | |
| SCHEMBL326701 | 0.74 | PTGS1 (0.47) | ALDH1A1LMNAHPGDHSD17B10 | |
| SCHEMBL28536934 | 0.72 | PTGS1 (0.50) | ALDH1A1LMNATSHR | |
| SCHEMBL16399076 | 0.69 | ALDH1A1 (0.55) | ALDH1A1ECE1FAAHCNR1CNR2 | |
| SCHEMBL19147460 | 0.69 | PTGS1 (0.54) | ALDH1A1ECE1FAAHLMNAPKM | |
| SCHEMBL18384184 | 0.69 | ALDH1A1 (0.31) | ALDH1A1LMNAHPGDNPSR1 | |
| SCHEMBL16006863 | 0.69 | PTGS1 (0.54) | ALDH1A1FAAHLMNAPKMTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250195679-A1 | ANTIBODY-DRUG CONJUGATE AND USE THEREOF | SHANGHAI HUAOTA BIOPHARMACEUTICAL CO., LTD. (CN) | 2025-06-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250195679-A1 | ANTIBODY-DRUG CONJUGATE AND USE THEREOF | ENTPD3, ENTPD1, NT5E | ALDH1A1 1826/4885ECE1 1670/4885FAAH 2479/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.